Physician profile
Nathan W Davis
NPI 1730165572
$961.97
in general payments reported to CMS, 2019-2025
18 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $204 · 2021: $55.81 · 2022: $37.00 · 2023: $86.08 · 2024: $162 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $324.42 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $94.61 | 2021-2024 | |
| Smith+Nephew, INC. | $81.12 | 2019-2020 | |
| Linvatec Corporation | $71.02 | 2023 | Colink Plating System, Allograft Tissue |
| Stryker Corporation | $68.51 | 2024 | Ortholoc 3di Crosscheck, Tenfuse, Phalinx |
| Allergan, INC. | $51.22 | 2020 | |
| Paratek Pharmaceuticals, INC. | $35.19 | 2024-2025 | Nuzyra |
| Biocomposites INC | $32.61 | 2024 | |
| Globus Medical, INC. | $31.23 | 2025 | Senza |
| Medtronic, INC. | $31.19 | 2024 | Intellis Adaptivestim |
| Abbott Laboratories | $23.33 | 2025 | Eterna |
| Dynasplint Systems INC. | $20.89 | 2025 | Dynasplint |
| Melinta Therapeutics, LLC | $19.26 | 2020 | |
| Tactile Systems Technology INC | $18.15 | 2025 | Flexitouch Plus, Nimbl |
| Djo, LLC | $17.95 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $15.31 | 2025 | |
| Arthrosurface Incorporated | $13.21 | 2019 | |
| Heron Therapeutics, INC. | $12.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.